| Anticancer Fund

Challenges and opportunities for cancer clinical trials in low- and middle-income countries

Bishal Gyawali, Gauthier Bouche, Nigel Crisp and Nicolas André. Challenges and opportunities for cancer clinical trials in low- and middle-income countries. Nature Cancer, 17 February 2020, DOI: 10.1038/s43018-020-0030-x

Tue, 02/18/2020 - 12:00

Cancer knows no boundaries, and neither do we

Tue, 02/04/2020 - 12:00

Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial

Bart J.T. Reymen, Marike W. van Gisbergen, Aniek J.G. Even, Catharina M.L. Zegers, Marco Das, Erik Vegt, Joachim E. Wildberger, Felix M. Mottaghy, Ala Yaromina, Ludwig J. Dubois, Wouter van Elmpt, Dirk De Ruysscher, Philippe Lambin - Nitroglycerin as a radiosensitizer in non-small cell lung cancer: Results of a prospective imaging-based phase II trial. Clinical and Translational Radiation Oncology, 21 (49-55), DOI: 10.1016/j.ctro.2019.12.002

Mon, 02/03/2020 - 12:00

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients

Ciska Verbaanderd, Ilse Rooman, Lydie Meheus, Isabelle Huys - On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients. Frontiers in Pharmacology, 31 January 2020, DOI: 10.3389/fphar.2019.01664

Mon, 02/03/2020 - 12:00

Transparancy of clinical trial reports assured

Wed, 01/22/2020 - 12:00

Clinical trials should remain transparent

Tue, 01/21/2020 - 12:00

Biased by design? Clinical trials and patient benefit in oncology

Pan Pantziarka, Ciska Verbaanderd, Lydie Meheus - Biased by design? Clinical trials and patient benefit in oncology. Future Medicine, 16 (3), doi.org/10.2217/fon-2019-0763

Tue, 01/14/2020 - 12:00

The Anticancer Fund’s recommendations to Horizon Europe

Wed, 12/18/2019 - 12:00